Pathology Watch
Salt Lake City, US · Founded 2017 · 6 known investors
A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.
Founders & leadership
Pathology Watch was founded in 2017 by Daniel Lambert.
DL
Daniel LambertFounder
YM
Yiannis MonovoukasNamed on SEC filing
GO
Gregory OsmondNamed on SEC filing
MT
Michael TornoNamed on SEC filing
Board
RS
Rick StratfordBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$28.9M disclosed across 3 rounds · 2019–2021
▶$22.3MraisedMar 2023 · 88 investors · Other TechnologyRule 506(c)
▶$22.3MraisedMar 2023 · 88 investors · Other Technology
Rule 506(c)Officers, directors & promoters on the filing
- Rick StratfordDirector
- Scott MattiviExecutive Officer
- Michael TornoExecutive Officer, Director
- Austin WaltersDirector
- Arjun DesaiDirector
- Daniel LambertExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $22.3M
- Sales commissions
- $67.5K
- Placement agents
- CEROS FINANCIAL SERVICES, INC.
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$4.3MraisedMay 2020 · 23 investors · Other TechnologyRule 506(b)
▶$4.3MraisedMay 2020 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TornoExecutive Officer, Director
- Daniel LambertExecutive Officer, Director
- Gregory OsmondExecutive Officer, Director
- Yiannis MonovoukasDirector
- Rick StratfordDirector
- Offering amount
- $5M
- Amount sold
- $4.3M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.3MraisedMay 2019 · 9 investors · Other TechnologyRule 506(b)
▶$2.3MraisedMay 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel LambertExecutive Officer, Director
- Yiannis MonovoukasDirector
- Rick StratfordDirector
- Gregory OsmondExecutive Officer, Director
- Michael TornoExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $2.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp181 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics180 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Medscape96 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with Pathology Watch for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pathology Watch do?
- A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.
- Who founded Pathology Watch?
- Pathology Watch was founded by Daniel Lambert in 2017.
- Who are Pathology Watch's investors?
- Pathology Watch's investors include 37 Angels, Beni Venture Capital, Harmonix Fund, Rock Creek Capital, SpringTide Ventures, Mana Ventures.
- How much funding has Pathology Watch raised?
- Pathology Watch has disclosed $28.9M raised across 3 rounds.
- Where is Pathology Watch headquartered?
- Pathology Watch is headquartered in Salt Lake City, US.